I-CORE - Israeli Centers Of Research Excellence I-CORE - Israeli Centers Of Research Excellence I-CORE - Israeli Centers Of Research Excellence Israeli Centers Of Research Excellence

Events

I-CORE Gene Regulation in Complex Human Disease member Prof. Dan Peer elected to Israel’s Young Academy of Science

I-CORE Gene Regulation in Complex Human Disease member Prof. Dan Peer elected to Israel’s Young Academy of Science

I-CORE Gene Regulation in Complex Human Disease member Prof. Dan Peer elected to Israel’s Young Academy of Science

I-CORE member Prof. Dan Peer, from the George S. Wise Faculty of Life Sciences at Tel Aviv University, has been selected to take part in Israel's Young Academy of Science. This organization was established by the Israel Academy of Sciences and Humanities and consists of young scholars in the humanities, social sciences and natural sciences.

The Young Academy of Science promotes excellence in scientific research, a closer relationship between academia and industry and cooperation between Israeli scientists and researchers from abroad. Its members are selected from among Israel's most promising young academics.
Prof. Dan Peer performed his training at Tel Aviv University and was a research associate at the Immune Disease Institute at Harvard Medical School. He was recruited to Tel Aviv University in 2008 to establish the Laboratory of NanoMedicine and became an I-CORE member in 2012. Prof. Peer’s work was among the first to demonstrate systemic delivery of RNA molecules using targeted nanocarriers to the immune system and he pioneered the use of RNA interference (RNAi) for in vivo validation of new therapeutic targets within the immune system. His work has been published in Science, Nature Nanotechnology and PNAS.
Prof. Peer currently leads an NIH-funded laboratory in the Dept. of Cell Research and Immunology, and is also affiliated with the Department of Materials Sciences and Engineering at the Faculty of Engineering, both at Tel Aviv University. He is the Director of the Focal Technology Area (FTA) on Nanomedicines for Personalized Theranostics, a multimillion-dollar, 5-year project supported by the Israel National Nanotechnology Initiative and by the Leona M. and Harry B. Helmsley Nanotechnology Research Fund. He has visiting academic appointments at Harvard Medical School, Boston, MA and at the Methodist Hospital Research Institute, Houston, TX.